pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
Emerg Infect Dis
; 23(3): 491-495, 2017 03.
Article
en En
| MEDLINE
| ID: mdl-28221108
ABSTRACT
Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA gene for 70% of multidrug-resistant and 96% of extensively drug-resistant Mycobacterium tuberculosis isolates from South Africa and Georgia. Assessment of pyrazinamide susceptibility may be prudent before using it in regimens for drug-resistant tuberculosis.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Pirazinamida
/
Farmacorresistencia Bacteriana Múltiple
/
Tuberculosis Extensivamente Resistente a Drogas
/
Amidohidrolasas
/
Antituberculosos
Tipo de estudio:
Risk_factors_studies
Límite:
Humans
País/Región como asunto:
Africa
/
Europa
Idioma:
En
Revista:
Emerg Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2017
Tipo del documento:
Article